XML 25 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Cash and cash equivalents    
Restricted cash $ 525 $ 606
Securities purchased under resale agreements 463 92
Premises and equipment, accumulated depreciation 8,602 7,540
Other assets, reserves for credit losses 25 85
Liabilities    
Outstanding balance $ 38,675 $ 42,952
Shareholders’ Equity    
Preferred shares, par value (in dollars per share) $ 1.667 $ 1.667
Preferred shares, authorized (in shares) 20,000,000 20,000,000
Preferred shares, outstanding (in shares) 1,600 1,600
Preferred shares, issued (in shares) 1,600 1,600
Common shares, par value (in dollars per share) $ 0.20 $ 0.20
Common shares, authorized (in shares) 3,600,000,000 3,600,000,000
Common shares, issued (in shares) 761,000,000 805,000,000
Common shares, outstanding (in shares) 761,000,000 805,000,000
Accumulated other comprehensive income (loss)    
Net unrealized debt securities gains (losses), tax $ 7 $ 20
Foreign currency translation adjustments, tax (330) (381)
Net unrealized pension and other postretirement benefits, tax (184) (236)
Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross 53,645 43,701
Financing receivables, reserves for credit losses 64 267
Card Member loans    
Cash and cash equivalents    
Financing receivables, gross 88,562 73,373
Financing receivables, reserves for credit losses 3,305 5,344
Other    
Cash and cash equivalents    
Financing receivables, reserves for credit losses 52 238
Variable Interest Entity, Primary Beneficiary    
Cash and cash equivalents    
Restricted cash 11 0
Restricted investments 32 47
Liabilities    
Outstanding balance 13,803 12,760
Variable Interest Entity, Primary Beneficiary | Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross 5,175 4,296
Variable Interest Entity, Primary Beneficiary | Card Member loans    
Cash and cash equivalents    
Financing receivables, gross $ 26,587 $ 25,908